Search Results for: ANKS6

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel MFSD14C major facilitator superfamily domain containing 14C
AGTRAP angiotensin II receptor associated protein
  • Signaling by BRAF and RAF fusions
APP amyloid beta precursor protein
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Tromethamine
  • Phenserine
  • Tetrathiomolybdate
  • CAD106
  • Mito-4509
  • Edonerpic
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Zinc acetate
  • Aluminium phosphate
  • Aluminum acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Alzheimer's disease (AD)
BCL2L2 BCL2 like 2
  • Navitoclax
BET1 Bet1 golgi vesicular membrane trafficking protein
  • COPII-mediated vesicle transport
  • COPI-mediated anterograde transport
C1GALT1 core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
  • Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)
  • O-linked glycosylation of mucins
C5 complement C5
  • Terminal pathway of complement
  • Activation of C3 and C5
  • Peptide ligand-binding receptors
  • G alpha (i) signalling events
  • Regulation of Complement cascade
  • Human immunoglobulin G
  • Eculizumab
  • Zinc
  • Copper
  • Ravulizumab
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
EMD emerin
  • Nuclear Envelope Breakdown
  • Initiation of Nuclear Envelope (NE) Reformation
  • Depolymerisation of the Nuclear Lamina
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Emery-Dreifuss muscular dystrophy
EMP1 epithelial membrane protein 1
IGFBP5 insulin like growth factor binding protein 5
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
MARCHF5 membrane associated ring-CH-type finger 5
PITPNC1 phosphatidylinositol transfer protein cytoplasmic 1
RTP2 receptor transporter protein 2
  • Olfactory Signaling Pathway
SMIM1 small integral membrane protein 1 (Vel blood group)
STRIT1 small transmembrane regulator of ion transport 1
STX7 syntaxin 7
TMEM120B transmembrane protein 120B
TMEM60 transmembrane protein 60
VAMP4 vesicle associated membrane protein 4
  • Retrograde transport at the Trans-Golgi-Network
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
VEZT vezatin, adherens junctions transmembrane protein

Page 1 out of 1 pages